Prospect of novel therapies in immune-mediated neuropathies
-
- M.D., Ph.D. Kuwahara Motoi
- Department of Neurology, Kindai University Faculty of Medicine
Bibliographic Information
- Other Title
-
- 免疫介在性ニューロパチーの新規治療展望
Abstract
<p>The efficacy of immunotherapies such as steroids, plasmapheresis, and intravenous immunoglobulin have been proven in various immune-mediated neuropathies. However, these treatments sometimes lack the efficacy in a part of patients with the immune-mediated neuropathies. In addition, anti-myelin associated glycoprotein (MAG) neuropathy is usually refractory to the treatments. Recently, novel therapies targeting a molecule which are associated with pathogenesis of immune-mediated diseases, have been developed. These molecularly targeted therapies are notable in immune-mediated neuropathies as novel drug candidates. In the present article, current treatments and future prospect of novel therapies in immune-mediated neuropathies will be reviewed.</p>
Journal
-
- Rinsho Shinkeigaku
-
Rinsho Shinkeigaku 64 (1), 1-7, 2024
Societas Neurologica Japonica